Heska (HSKA) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- S&P Global explores potential separation of Capital IQ business
- Wall Street ends higher on revived AI momentum
- Nebius Group shares jump after France data center funding
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
- Seagate Technology (STX) Tops Q1 EPS by 29c, Offers Guidance
Heska Reports Financial Results for the Second Quarter of 2015
July 29, 2015 9:01 AM EDTLOVELAND, Colo., July 29, 2015 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its second quarter ended June 30, 2015.
Second Quarter 2015 Highlights with Prior Year Comparison:
Income from Operations was up nearly 100% to $1.829 million, from $917 thousand. Blood Analyzer and Consumables revenue rose 29% to $10.1 million, from $7.8 million. Core Companion Animal revenue was up... MoreHeska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes
July 28, 2015 4:21 PM EDTLOVELAND, Colo., July 28, 2015 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today the availability of the new Element i® Immunodiagnostic Analyzer. Element i performs immediate in-clinic testing and screening for key health concerns, including thyroid disorders, Cushing's disease... More



